Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Barclays PLC Major Shareholding Notification 2021

Feb 11, 2021

5250_rns_2021-02-11_a94abf37-4cd5-4637-8b3f-195c7eb22728.html

Major Shareholding Notification

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

FORM 8.3 - WILLIS TOWERS WATSON PLC

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 10 February 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
2,203,678 1.71% 609,592 0.47%
(2) Derivatives (other than options):
273,127 0.21% 406,831 0.32%
(3) Options and agreements to
purchase/sell: 6,000 0.00% 6,000 0.00%
(4) TOTAL:
2,482,805 1.93% 1,022,423 0.79%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale Number of relevant securities Price per unit
Purchase 2 229.8000 USD
Purchase 9 228.0355 USD
Purchase 11 227.2000 USD
Purchase 28 227.2500 USD
Purchase 100 225.6800 USD
Purchase 100 226.7000 USD
Purchase 118 228.2100 USD
Purchase 300 227.5225 USD
Purchase 300 225.6566 USD
Purchase 400 225.3250 USD
Purchase 400 226.6850 USD
Purchase 500 225.6400 USD
Purchase 586 228.9327 USD
Purchase 700 225.6741 USD
Purchase 891 226.1065 USD
Purchase 953 226.5308 USD
Purchase 1,244 226.1286 USD
Purchase 1,300 225.6529 USD
Purchase 2,603 229.5263 USD
Purchase 2,964 226.8010 USD
Purchase 3,968 225.6300 USD
Purchase 5,483 227.3045 USD
Purchase 13,730 225.6701 USD
Purchase 16,933 226.3422 USD
Purchase 53,422 227.8122 USD
Sale 11 227.7172 USD
Sale 14 227.0800 USD
Sale 14 227.2500 USD
Sale 100 225.5700 USD
Sale 100 229.7700 USD
Sale 100 227.4200 USD
Sale 100 226.7000 USD
Sale 186 229.0218 USD
Sale 200 226.4200 USD
Sale 200 229.1875 USD
Sale 300 225.7750 USD
Sale 466 225.6300 USD
Sale 716 226.5899 USD
Sale 890 226.1058 USD
Sale 1,383 229.3562 USD
Sale 2,166 227.6671 USD
Sale 2,257 228.0568 USD
Sale 2,300 227.8026 USD
Sale 2,364 227.9693 USD
Sale 2,449 227.5558 USD
Sale 2,471 228.0731 USD
Sale 2,622 226.0731 USD
Sale 2,900 225.6572 USD
Sale 3,264 226.8673 USD
Sale 3,502 225.6323 USD
Sale 3,693 228.5877 USD
Sale 3,994 227.9187 USD
Sale 4,593 227.5368 USD
Sale 4,867 227.3973 USD
Sale 4,873 228.1019 USD
Sale 5,213 228.1617 USD
Sale 6,414 227.3276 USD
Sale 12,899 227.6382 USD
Sale 13,729 225.6701 USD
Sale 16,175 226.3924 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD
Nature of transaction

(Note 6)
Number of relevant securities

(Note 7)
Price per unit

(Note 5)

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option
Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)

(ii) Exercising

Product name,

e.g. call option
Number of securities Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)
Details Price per unit

(if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 11 Feb 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Call Options Purchased 6,000 220.0000 American Jul 16, 2021
Put Options Purchased -6,000 200.0000 American Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210211005478/en/

BARCLAYS PLC